Ipratropium bromide/Salbutamol Neutec 0.5/2.5 mg per 2.5 ml nebuliser solution Irlanda - anglès - HPRA (Health Products Regulatory Authority)

ipratropium bromide/salbutamol neutec 0.5/2.5 mg per 2.5 ml nebuliser solution

neutec inhaler ireland limited - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - salbutamol and ipratropium bromide

ATROVENT ipratropium bromide monohydrate 21 microgram per metered dose inhalation aerosol can Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

atrovent ipratropium bromide monohydrate 21 microgram per metered dose inhalation aerosol can

boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 21 microgram/actuation - inhalation, pressurised - excipient ingredients: ethanol absolute; citric acid; purified water; norflurane - atrovent metered aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with asthma and chronic obstructive pulmonary disease (copd).

IPRATRIN UNI-DOSE ipratropium bromide monohydrate 250microgram/1mL inhalation ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

ipratrin uni-dose ipratropium bromide monohydrate 250microgram/1ml inhalation ampoule

alphapharm pty ltd - ipratropium bromide monohydrate -

IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION Canadà - anglès - Health Canada

ipratropium bromide and salbutamol sulphate inhalation solution

juno pharmaceuticals corp. - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide (ipratropium bromide monohydrate) 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

APO-IPRATROPIUM ipratropium bromide anhydrous 500 microgram/mL inhalation ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

apo-ipratropium ipratropium bromide anhydrous 500 microgram/ml inhalation ampoule

aspen pharma pty ltd - ipratropium bromide monohydrate -

APO-IPRATROPIUM ipratropium bromide anhydrous 250 microgram/mL inhalation ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

apo-ipratropium ipratropium bromide anhydrous 250 microgram/ml inhalation ampoule

aspen pharma pty ltd - ipratropium bromide monohydrate -

IPRAVENT ipratropium bromide 500 microgram/1 mL inhalation ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

ipravent ipratropium bromide 500 microgram/1 ml inhalation ampoule

pfizer australia pty ltd - ipratropium bromide monohydrate -

IPRAVENT ipratropium bromide 250 microgram/1 mL inhalation ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

ipravent ipratropium bromide 250 microgram/1 ml inhalation ampoule

pfizer australia pty ltd - ipratropium bromide monohydrate -

ATROVENT NASAL FORTE ipratropium bromide monohydrate 44 microgram/actuation spray solution Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

atrovent nasal forte ipratropium bromide monohydrate 44 microgram/actuation spray solution

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - ipratropium bromide, quantity: 0.6 mg/ml - spray, solution - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; disodium edetate; purified water; benzalkonium chloride - for the symptomatic relief of rhinorrhoea associated with allergic and non-allergic perennial rhinitis, and the common cold.

ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

atrovent nasal ipratropium bromide monohydrate 22 microgram/actuation spray solution

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - ipratropium bromide, quantity: 0.3 mg/ml - spray, solution - excipient ingredients: sodium hydroxide; disodium edetate; hydrochloric acid; purified water; benzalkonium chloride; sodium chloride - symptomatic relief of rhinorrhoea associated with allergic and non-allergic perennial rhinitis. indications as at 28 april 1999: for the symptomatic relief of rhinorrhoea associated with allergic and non-allergic perennial rhinitis, and the common cold.